Please turn JavaScript on

Oncology Central

Receive updates from Oncology Central for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Oncology Central. Unsubscribe at any time.

Site title: Home - Oncology Central

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.58 / day

Message History

New study reveals Viagra's active ingredient sildenafil restricts cancer spread by blocking cholesterol transport. Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world’s best-known therapy for erectile dysfunction. In the future, thi...

Read full story

Researchers are studying the role of copper in the spread of triple negative breast cancer, and whether reducing copper levels in the body could help prevent this. Copper is an essential mineral that the body needs in small amounts to stay healthy, also known as a metal micronutrient. However, recent research has shown it can help triple negative breast ...

Read full story

Cancer diagnosis during adolescence and young adulthood disrupts critical developmental milestones, creating unique psychosocial challenges that persist well beyond treatment completion. In this article, four expert oncology social workers discuss the distinct mental health needs of AYA patients with cancer, from recognizing subtle warning signs of distress to imp...

Read full story

New research reveals NICE referral criteria used by GPs to decide who should be referred for further breast cancer risk assessment and specialist care miss up to 95% of women under 50 who go on to develop breast cancer within 10 years. Researchers at the University of Cambridge and The Institute of Cancer Research, London analysed data from ...

Read full story

Cretostimogene grenadenorepvec after Bacillus Calmette-Guérin failure produces complete responses in 75% of patients while preserving bladder function. An

Read full story